Northern Alberta Institute of Technology

www.nait.ca
Edmonton, Canada

The Northern Alberta Institute of Technology is a polytechnic and applied science institute located in Edmonton, Alberta, Canada. NAIT provides careers programs in applied research, technical training, applied education, and learning designed to meet the demands of Alberta's technical and knowledge-based industries. NAIT offers approximately 140 credit programs leading to applied degrees, diplomas and certificates. There are approximately 8,400 full-time students, 20,500 students in continuing education and part-time studies, 12,300 apprentices anticipated for 2012, and more than 20,000 registrants for customized corporate based training. NAIT also attracts international students from 77 countries. NAIT is similar to an Institute of technology or university of applied science as termed in other jurisdictions. The university press, The Nugget, is a member of CUP.NAIT is a member of the Alberta Rural Development Network. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

REDONDO BEACH, CA / ACCESSWIRE / December 13, 2016 / BioLargo, Inc. (OTCQB: BLGO), owner and developer of the breakthrough AOS (Advanced Oxidation System), a low-energy high-efficiency clean water technology, announced the start of a relationship with Chicago Bridge & Iron, NV (NYSE: CBI). According to the press release and a number of recent interviews with BioLargo's President & CEO, Dennis P. Calvert, the new relationship was formed to support the commercialization of BioLargo's proprietary technology and to provide independent performance verification. BioLargo also reports the AOS has been proven to disinfect and decontaminate water better, faster and at a lower cost than any other competing technology. Based on the breadth and significance of the technical performance claims for its AOS, BioLargo has a broad range of commercial opportunities for large industrial applications that must contend with water such as: maritime ballast water management systems, wastewater treatment, environmental remediation, food safety, oil & gas, mining, and agriculture. Its future uses also promise to impact the drinking water industry, including municipal, home use, and emerging nations. The company is also busy commercializing its new "CupriDyne Clean", an industrial odor control product launched last May. The company reports that the product is so effective and low-cost it is gaining rapid traction through trials with leaders within the waste handling industry and that it has had some early sales. Management believes sales will continue to climb, as they finalize supplier agreements with large multi-location customer accounts. CupriDyne Clean may also have an important role to play in industries that contend with volatile organic compounds like hydrogen sulfide (H2S) that impact air quality and safety. Dennis P. Calvert, President & CEO of BioLargo commented, "All of our technologies at BioLargo can serve a wide array of industrial customers that want clean water and clean air. Our mission to 'Make Life Better' includes helping industry tackle operational challenges cost effectively. That intersection of service is likely where our new relationship with CB&I will shine the brightest and we look forward to working with the exceptional team at CB&I to serve industry." With more than 40,000 employees, $13 billion in annual revenue and over $20 billion in future contracts, CB&I is a world-leading engineering, procurement, fabrication, and construction company, and a provider of environmental and infrastructure services. CB&I builds oil refineries, liquefied natural gas terminals, wastewater treatment plants, offshore platforms, and power plants. CB&I is also the world's largest tank construction company and builds tanks for the oil & gas, mining, water, and wastewater industries. The company also remediates hazardous waste problems. Clean water and clean air are at the heart of many of industries served by CB&I and BioLargo's technologies. Details in the first announcement were slim. This news sends notice to the investment world and to industry that Biolargo's technologies can have an important role to play in helping solve air and water contamination problems in a safe, effective and affordable way. Calvert has been quick to point out that the current version of the AOS has been engineered to serve entry-level clients and that important scale-up work is required to serve very large-scale industrial clients. BioLargo Water's research team recently showcased the first pre-commercial prototype of its AOS water treatment system, billed as the lowest cost and highest impact, scalable clean water technology in the world. By combining a cutting-edge carbon matrix, advanced iodine chemistry, and electrolysis, this technology rapidly and inexpensively eliminates bacteria and chemical contaminants in water without leaving residual toxins. University of Alberta researchers, in collaboration with BioLargo Water Scientists, have confirmed test results that validate the AOS achieves unprecedented rates of disinfection, eliminating infectious biological pathogens such as Salmonella, Listeria and E. coli. The AOS has also been proven effective in oxidizing and removing hard-to-manage soluble organics acids, aromatic compounds, and solvents faster than existing technologies and with very little input energy. Proven test results validate its important role for extremely high oxidation potential to tackle a long "watch list" of contaminants identified by the EPA. The company reports that future generations of the AOS will include the extraction and harvesting of important contaminants like sulfur, nitrates, phosphorus, and even heavy metals. The company's first "Alpha" AOS was constructed in collaboration with the Northern Alberta Institute of Technology (NAIT)'s Center for Sensors and Systems Integration and with NAIT's Applied Bio/Nanotechnology Industrial Research Chair. Its "Beta" unit is expected to be ready for commercial trials in 2017. What places the AOS above competing technologies is its exceptionally high rate of disinfection (100x more effective than the competition, as verified in poultry production applications) and remarkably low capital and operational costs, made possible by its extremely low amount of electrical energy required to power the oxidation process. Studies have shown the AOS to achieve remarkable rates of disinfection at less than 1/20th the electrical energy input of competing technologies. The AOS is scalable and modular in design to meet a wide variety of needs in the marketplace. BioLargo is already working on what it calls the "Gen 2 AOS" for ultra-high flow rates. Because the markets for the AOS are very large and the needs so great, management reports that they believe it is only a matter of time before industry adopts this new breakthrough low cost technology. Oil and gas companies such as Exxon Mobil Corporation (NYSE: XOM), Halliburton Company (NYSE: HAL), Schlumberger Limited (NYSE: SLB), Chevron Corporation (NYSE: CVX) and Royal Dutch Shell plc (NYSE: RDS-A) could dramatically reduce water transportation, sourcing and disposal costs by adopting the AOS. The AOS has been shown to be cost effective at removing problematic contaminants from oil & gas "produced water", and any technology such as the AOS that could cost-effectively enable water recycling on-site could slash costs and greatly improve the bottom line for many producers that are now suffering big losses due to persistently low oil prices. It could also alleviate the costly problem of injecting produced water deep into injection wells, and simultaneously reduce pollution. The maritime industry has increasing regulatory pressure to eliminate the detrimental transfer and release of invasive marine species through the discharge of ballast water. This issue prompted the International Maritime Organization to impose regulations for the treatment and discharge of ballast water, and these new rules are scheduled to come into force beginning September of 2017. An estimated 65,000 ships must adopt ballast water treatment systems type approved under the International Convention for the Control and Management of Ships' Ballast Water and Sediments, 2004 (BWMC). Approved systems must disinfect seawater to specified standards without adding any toxic elements to the discharged water. Global Water Intelligence estimates that the average cost for each ballast water management system will be more than $750,000 and the total cost to outfit every vessel will be about $46.5 billion. Because it is the highest impact, lowest cost, lowest energy technology known that can solve this problem, the AOS is could be the most practical solution to maritime operators such as DryShips, Inc. (NASDAQ: DRYS), Navios Maritime Holdings, Inc. (NASDAQ: NM), Diana Shipping, Inc. (NYSE: DSX), Sino-Global Shipping America, Ltd. (NASDAQ: SINO), Diana Containerships Inc. (DCIX) and several others. In an effort to reduce the incidence of foodborne illness in the poultry industry, the U.S. Department of Agriculture's Food Safety and Inspection Service, FSIS, announced new, stricter federal standards to reduce Salmonella and Campylobacter in ground chicken and turkey products, as well as in raw chicken breasts, legs, and wings. The new regulations took effect July 1, 2016 and have the potential to impact sales of poultry processing operations of Tyson Foods, Inc. (NYSE: TSN), Pilgrims Pride Corporation, (NASDAQ: PPC), Sanderson Farms, Inc., (NASDAQ: SAFM), Hormel Foods Corporation, (NYSE: HRL), Perdue, Cargill, Smithfield Food, Inc., Conagra Foods, Inc., and every other poultry processor. Researchers at the University of Alberta confirmed that the AOS could be highly effective in reducing cross-contamination of pathogens when poultry is washed in chill tanks. Water quality of municipal water systems is also a growing concern and a few large water treatment companies that provide water services to millions of U.S. residents are American Water Works Company, Inc., (NYSE: AWK), American States Water Company (NYSE: AWR), Aqua America, Inc. (NYSE: WTR) and Veolia Environnement S.A. (OTC: VEOEY). The need for a better and lower cost clean water technology is urgent and CB&I may just be the perfect company to support implementation of breakthrough low-cost water and air treatment technologies developed by BioLargo, Inc. that can help solve problems across such a broad spectrum of industries. Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx. REDONDO BEACH, CA / ACCESSWIRE / December 13, 2016 / BioLargo, Inc. (OTCQB: BLGO), owner and developer of the breakthrough AOS (Advanced Oxidation System), a low-energy high-efficiency clean water technology, announced the start of a relationship with Chicago Bridge & Iron, NV (NYSE: CBI). According to the press release and a number of recent interviews with BioLargo's President & CEO, Dennis P. Calvert, the new relationship was formed to support the commercialization of BioLargo's proprietary technology and to provide independent performance verification. BioLargo also reports the AOS has been proven to disinfect and decontaminate water better, faster and at a lower cost than any other competing technology. Based on the breadth and significance of the technical performance claims for its AOS, BioLargo has a broad range of commercial opportunities for large industrial applications that must contend with water such as: maritime ballast water management systems, wastewater treatment, environmental remediation, food safety, oil & gas, mining, and agriculture. Its future uses also promise to impact the drinking water industry, including municipal, home use, and emerging nations. The company is also busy commercializing its new "CupriDyne Clean", an industrial odor control product launched last May. The company reports that the product is so effective and low-cost it is gaining rapid traction through trials with leaders within the waste handling industry and that it has had some early sales. Management believes sales will continue to climb, as they finalize supplier agreements with large multi-location customer accounts. CupriDyne Clean may also have an important role to play in industries that contend with volatile organic compounds like hydrogen sulfide (H2S) that impact air quality and safety. Dennis P. Calvert, President & CEO of BioLargo commented, "All of our technologies at BioLargo can serve a wide array of industrial customers that want clean water and clean air. Our mission to 'Make Life Better' includes helping industry tackle operational challenges cost effectively. That intersection of service is likely where our new relationship with CB&I will shine the brightest and we look forward to working with the exceptional team at CB&I to serve industry." With more than 40,000 employees, $13 billion in annual revenue and over $20 billion in future contracts, CB&I is a world-leading engineering, procurement, fabrication, and construction company, and a provider of environmental and infrastructure services. CB&I builds oil refineries, liquefied natural gas terminals, wastewater treatment plants, offshore platforms, and power plants. CB&I is also the world's largest tank construction company and builds tanks for the oil & gas, mining, water, and wastewater industries. The company also remediates hazardous waste problems. Clean water and clean air are at the heart of many of industries served by CB&I and BioLargo's technologies. Details in the first announcement were slim. This news sends notice to the investment world and to industry that Biolargo's technologies can have an important role to play in helping solve air and water contamination problems in a safe, effective and affordable way. Calvert has been quick to point out that the current version of the AOS has been engineered to serve entry-level clients and that important scale-up work is required to serve very large-scale industrial clients. BioLargo Water's research team recently showcased the first pre-commercial prototype of its AOS water treatment system, billed as the lowest cost and highest impact, scalable clean water technology in the world. By combining a cutting-edge carbon matrix, advanced iodine chemistry, and electrolysis, this technology rapidly and inexpensively eliminates bacteria and chemical contaminants in water without leaving residual toxins. University of Alberta researchers, in collaboration with BioLargo Water Scientists, have confirmed test results that validate the AOS achieves unprecedented rates of disinfection, eliminating infectious biological pathogens such as Salmonella, Listeria and E. coli. The AOS has also been proven effective in oxidizing and removing hard-to-manage soluble organics acids, aromatic compounds, and solvents faster than existing technologies and with very little input energy. Proven test results validate its important role for extremely high oxidation potential to tackle a long "watch list" of contaminants identified by the EPA. The company reports that future generations of the AOS will include the extraction and harvesting of important contaminants like sulfur, nitrates, phosphorus, and even heavy metals. The company's first "Alpha" AOS was constructed in collaboration with the Northern Alberta Institute of Technology (NAIT)'s Center for Sensors and Systems Integration and with NAIT's Applied Bio/Nanotechnology Industrial Research Chair. Its "Beta" unit is expected to be ready for commercial trials in 2017. What places the AOS above competing technologies is its exceptionally high rate of disinfection (100x more effective than the competition, as verified in poultry production applications) and remarkably low capital and operational costs, made possible by its extremely low amount of electrical energy required to power the oxidation process. Studies have shown the AOS to achieve remarkable rates of disinfection at less than 1/20th the electrical energy input of competing technologies. The AOS is scalable and modular in design to meet a wide variety of needs in the marketplace. BioLargo is already working on what it calls the "Gen 2 AOS" for ultra-high flow rates. Because the markets for the AOS are very large and the needs so great, management reports that they believe it is only a matter of time before industry adopts this new breakthrough low cost technology. Oil and gas companies such as Exxon Mobil Corporation (NYSE: XOM), Halliburton Company (NYSE: HAL), Schlumberger Limited (NYSE: SLB), Chevron Corporation (NYSE: CVX) and Royal Dutch Shell plc (NYSE: RDS-A) could dramatically reduce water transportation, sourcing and disposal costs by adopting the AOS. The AOS has been shown to be cost effective at removing problematic contaminants from oil & gas "produced water", and any technology such as the AOS that could cost-effectively enable water recycling on-site could slash costs and greatly improve the bottom line for many producers that are now suffering big losses due to persistently low oil prices. It could also alleviate the costly problem of injecting produced water deep into injection wells, and simultaneously reduce pollution. The maritime industry has increasing regulatory pressure to eliminate the detrimental transfer and release of invasive marine species through the discharge of ballast water. This issue prompted the International Maritime Organization to impose regulations for the treatment and discharge of ballast water, and these new rules are scheduled to come into force beginning September of 2017. An estimated 65,000 ships must adopt ballast water treatment systems type approved under the International Convention for the Control and Management of Ships' Ballast Water and Sediments, 2004 (BWMC). Approved systems must disinfect seawater to specified standards without adding any toxic elements to the discharged water. Global Water Intelligence estimates that the average cost for each ballast water management system will be more than $750,000 and the total cost to outfit every vessel will be about $46.5 billion. Because it is the highest impact, lowest cost, lowest energy technology known that can solve this problem, the AOS is could be the most practical solution to maritime operators such as DryShips, Inc. (NASDAQ: DRYS), Navios Maritime Holdings, Inc. (NASDAQ: NM), Diana Shipping, Inc. (NYSE: DSX), Sino-Global Shipping America, Ltd. (NASDAQ: SINO), Diana Containerships Inc. (DCIX) and several others. In an effort to reduce the incidence of foodborne illness in the poultry industry, the U.S. Department of Agriculture's Food Safety and Inspection Service, FSIS, announced new, stricter federal standards to reduce Salmonella and Campylobacter in ground chicken and turkey products, as well as in raw chicken breasts, legs, and wings. The new regulations took effect July 1, 2016 and have the potential to impact sales of poultry processing operations of Tyson Foods, Inc. (NYSE: TSN), Pilgrims Pride Corporation, (NASDAQ: PPC), Sanderson Farms, Inc., (NASDAQ: SAFM), Hormel Foods Corporation, (NYSE: HRL), Perdue, Cargill, Smithfield Food, Inc., Conagra Foods, Inc., and every other poultry processor. Researchers at the University of Alberta confirmed that the AOS could be highly effective in reducing cross-contamination of pathogens when poultry is washed in chill tanks. Water quality of municipal water systems is also a growing concern and a few large water treatment companies that provide water services to millions of U.S. residents are American Water Works Company, Inc., (NYSE: AWK), American States Water Company (NYSE: AWR), Aqua America, Inc. (NYSE: WTR) and Veolia Environnement S.A. (OTC: VEOEY). The need for a better and lower cost clean water technology is urgent and CB&I may just be the perfect company to support implementation of breakthrough low-cost water and air treatment technologies developed by BioLargo, Inc. that can help solve problems across such a broad spectrum of industries. Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.


Lagerquist O.,Northern Alberta Institute of Technology | Mang C.S.,University of British Columbia | Collins D.F.,University of Alberta
Experimental Brain Research | Year: 2012

Unilateral training involving voluntary contractions, neuromuscular electrical stimulation (NMES), or a combination of the two can increase the excitability of neural circuits bilaterally within the CNS. Many rehabilitation programs are designed to promote such neuroplasticity to improve voluntary movement following CNS damage. While much is known about this type of activity-dependent plasticity for the muscles that dorsi-flex the ankle, similar information is not available for the plantar-flexors. Presently, we assessed the excitability of corticospinal (CS) and spinal circuits for both soleus (SOL) muscles before and after voluntary contractions of the right plantar-flexors (VOL; 5 s on-5 s off, 40 min), NMES of the right tibial nerve (tnNMES; 5 s on-5 s off, 40 min), or both together (V + tnNMES). CS excitability for the right (rSOL) and left SOL (lSOL) muscles was assessed by quantifying motor evoked potentials elicited by transcranial magnetic stimulation. Spinal excitability was assessed using measures from the ascending limb of the M-wave versus H-reflex recruitment curve. CS excitability did not change for rSOL (the activated muscle) or lSOL following any condition. In contrast, there was a marked increase in spinal excitability for rSOL, but only following V + tnNMES; the slope of the M-wave versus H-reflex recruitment curve increased approximately twofold (pre = 7.9; post = 16.2) and H-reflexes collected when the M-wave was ∼5 % of the maximal M-wave (Mmax) increased by ∼1.5× (pre = 19 % Mmax, post = 29 % Mmax). Spinal excitability for lSOL did not change following any condition. Thus, only voluntary contractions that were coupled with NMES increased CNS excitability, and this occurred only in the ipsilateral spinal circuitry. These results are in marked contrast to previous studies showing NMES-induced changes in CS excitability for every other muscle studied and suggest that the mechanisms that regulate activity-dependent neuroplasticity are different for SOL than other muscles. Further, while rehabilitation strategies involving voluntary training and/or NMES of the plantar-flexors may be beneficial for producing movement and reducing atrophy, a single session of low-intensity NMES and voluntary training may not be effective for strengthening CS pathways to the SOL muscle. © 2012 Springer-Verlag.


Riess K.J.,Northern Alberta Institute of Technology
Journal of Human Sport and Exercise | Year: 2014

In recent years there has been an increase in participation in timed running events. With this increase, the motivation for individuals to run their best has motivated the running shoe industry to make design changes to traditional running foot wear in an effort to improve running economy (RE) and decrease running times. One such design change has been to incorporate mechanical springs (MS) into the midsole of the running shoe. Evaluation of this technology has yet to be performed. This study recruited 17 runners (12 male) and had them run at a submaximal steady state speed for 2 bouts of five minutes at a speed of 3.13 m.sec-1. The order of shoe condition was randomly assigned and the subjects ran one interval in their own running shoe (OS) and one interval in MS shoes. Metabolic data and heart rate data were averaged over the last three of the five minute efforts. No significant difference was found between MS and OS with regards to shoe weight. Running in MS resulted in lower, non-significant values for steady state ventilation and steady state heart rate. Oxygen consumption was significantly lower in MS compared to OS in both absolute (MS: 2.35 ± 0.47 L.min-1 vs. OS: 2.40 ± 0.473 L.min-1, P=0.022) and relative (MS: 34.67 ± 4.35 ml.kg-1.min-1 vs. OS: 35.34 ± 4.58 ml.kg- 1.min-1, P=0.033) terms. Running in shoes fitted with MS technology improves running economy over OS and this technology may assist athletes achieve their best running times. © Faculty of Education. University of Alicante.


News Article | November 22, 2016
Site: www.marketwired.com

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES Anchor Capital Corporation (TSX VENTURE:ANC.P) ("Anchor" or the "Corporation") is pleased to announce details concerning its proposed qualifying transaction involving a proposed business combination with Mark One Lifestyle, Inc. ("Mark One"). Mark One is a private consumer electronics company, whose key products consist of internet-connected lifestyle devices that automatically track food consumption so consumers can make healthier decisions in real-time. Anchor has entered into a non-binding letter agreement with Mark One dated October 26, 2016 (the "Letter Agreement"), pursuant to which Anchor and Mark One intend to complete a business combination (the "Transaction") pursuant to which Anchor will be renamed "Mark One Lifestyle Corp." ("Newco"). Upon completion of the Transaction, Newco will continue to carry on the business of Mark One and Newco is expected to be a Tier 2 industrial issuer. Pursuant to the Transaction, it is expected that an aggregate of 30,000,000 common shares in the capital of Newco (the "Newco Common Shares") will be issued to the current shareholders of Mark One in exchange for all of the issued and outstanding common stock and securities convertible into common stock of Mark One (the "Mark One Common Shares") at a deemed price of CAD$0.50 per Newco Common Share for an aggregate deemed consideration of CAD$15,000,000, exclusive of (i) Newco Common Shares issued to subscribers under the Mark One Private Placement and the Mark One Financing (both as defined below). Each 3.5 of the 5,514,000 issued and outstanding Anchor Common Shares (as defined below) will be consolidated into one Newco Common Share (the "Consolidation"). Each 3.5 outstanding stock options and agents' options of Anchor will be exchanged for one stock option or agent's option of Newco to reflect the Consolidation and the exercise price will be adjusted proportionately in accordance with their respective terms. In connection with the Transaction, Opus 3 Capital Inc. shall be paid a finder's fee of CAD$750,000 which shall be payable as to CAD$225,000 in cash and by the issuance of 1,050,000 Newco Common Shares, subject to approval of the TSX Venture Exchange (the "TSXV"). It is intended that the Transaction, when completed, will constitute the qualifying transaction of the Corporation pursuant to Policy 2.4 of the TSX Venture Exchange Corporate Finance Manual. The Transaction is an arm's length transaction and is subject to the policies of the TSXV relating to qualifying transactions, as well as shareholder approval of each of Anchor and Mark One. Mark One is a manufacturer and marketer of internet-connected lifestyle devices that automatically track food and beverage consumption, working with fitness trackers to provide consumers with the other half of the equation they need to get and stay healthy. Mark One's product offerings include Pryme Vessyl, a smart cup that helps people calculate and track their unique hydration needs. Pryme Vessyl is currently being used in over 100 countries, in studies to assess its ability to impact outcomes in diseases like kidney stones, and in workplace wellness programs to improve employee health engagement by highlighting the impact of hydration on things like concentration, short-term memory, and productivity. Mark One was founded in Kingston, Ontario, Canada in 2007 and later opened its headquarters in San Francisco, CA USA in 2013. Mark One was co-founded by Yves Behar, a renowned industrial designer and Chief Creative Officer at Jawbone. Mark One's Chief Executive Officer is Mrs. Helen Thomas, an experienced consumer electronics executive and former CEO of LeapFrog China. Mark One's investors include Intel Capital Corporation, Horizons Ventures (family office of Lee Ka-Shing) and Felicis Ventures, among others. Mark One is a private corporation incorporated under the laws of the State of Delaware on October 22, 2013. Mark One's head office is located in San Francisco, California. Mark One has one wholly owned subsidiary in Canada called Paperwhite, Inc. Intel Capital Corporation incorporated in Delaware, USA and OurCrowd (Investment in Mark One) L.P. formed in the British Virgin Islands and their affiliates are the only Control Persons (as such term is defined in TSXV policies) of Mark One. Mark One is in the process of issuing secured promissory notes convertible into Mark One Common Shares (the "New Mark One Notes") and 300,000 warrants to purchase common stock of Mark One (the "New Mark One Warrants") as part of a maximum CAD$3,000,000 financing on a private placement basis. In connection with the Transaction, every CAD$0.40 of principal amount of the New Mark One Notes will be exchanged for one Newco Common Share and the New Mark One Warrants will be exchanged for warrants of Newco on the basis of one Newco warrant for every ten Newco Common Shares issued, with each such Newco warrant to have a term of three years and an exercise price of CAD$0.65 on a post-Transaction basis (the "Mark One Financing"). Pursuant to the Letter Agreement, the parties have agreed to use their "commercially reasonable efforts" to cause Mark One to complete a private placement (the "Mark One Private Placement") of subscription receipts of Mark One (the "Subscription Receipts") at a price of CAD$0.50 per Subscription Receipt for gross proceeds of a minimum of CAD$10,000,000 and a maximum of CAD$15,000,000. Each Subscription Receipt will be automatically converted into one Newco Common Share concurrent with the completion of the Transaction at no additional cost to the holder. Mark One intends to engage a syndicate of agents to be determined (the "Agents") to act as agents on a "commercially reasonable efforts" basis for the Mark One Private Placement, and in connection therewith intends to pay a commission to the Agents of up to 7% with a minimum of 5.5% going to the selling group participants. The Agents will also be granted that number of broker warrants equal to 7% of the number of Subscription Receipts sold by the Agents in connection with the Private Placement (the "Broker Warrants"), with each Broker Warrant entitling the holder to purchase one Newco Common Share at a price of CAD$0.50 per share for a period of 18 months from the date of closing of the Transaction. A further press release announcing additional details will be issued in due course. The net proceeds from the Mark One Private Placement will be used for bringing to market new consumer products, purchase of inventory, marketing, and for general working capital purposes. The net proceeds of the Mark One Private Placement will be held in escrow and released concurrent with the completion of the Transaction. The Board of Directors of Newco is expected to consist of five directors, including Helen Thomas (the current Chief Executive Officer of Mark One), Arlene Dickinson (a current director of Anchor), one mutually agreed upon independent nominee and two other nominees of Mark One, provided that such persons are eligible to act as directors pursuant to the requirements of applicable corporate legislation and subject to approval of the TSXV. Upon completion of the Transaction, the officers of Newco will be appointed by the Board of Directors of Newco and will include Helen Thomas as Chief Executive Officer, Osei Van Horne as Vice-President, Operations, Dr. Hanson Lenyou as Vice-President, Health, Alex Prevoteau as Director, Software, as well as a Chief Financial Officer and a Corporate Secretary to be determined by the Board of Directors of Newco. The following is a brief description and jurisdiction of residence of each of the proposed members of management and directors of Newco. Helen Thomas - CEO, Chairman of the Board of Directors Ms. Thomas is a seasoned executive with over twenty years of experience spearheading strategic partnerships, mergers and acquisitions (M&A), and marketing campaigns for complex, global business development initiatives for companies across education technology, Internet of Things (IoT), and media industries. Her leadership has rapidly grown multiple companies from zero to tens and hundreds of millions in revenue through effective brand positioning and distribution strategies to ensure product reach their targeted audience on time the world over. Ms. Thomas was the Chairman, Co-founder and CEO of Touchjet Inc., a company focused on the development of touchscreen smart projectors and touchscreen smart televisions from 2014 to 2016, where she successfully launched two award-wining IoT products with cloud based collaborative software. Prior to that, she was the founding President of BlueFocus Communications Group of America Inc., from 2012 to 2014, a wholly owned subsidiary of the largest digital marketing communication company in China, BlueFocus Communication Group Co., Ltd. She built BlueFocus Communications Group of America Inc. to over $150 million via strategic acquisitions including fuseproject in Silicon Valley and Vision 7 in Canada. As part of the senior founding team at Livescribe Inc., a global leader in the design and manufacturing of smart pens from 2008 to 2012, she led worldwide sales and achieved $50 million annual revenue within 3 years and built distribution in over 45 countries. She started her career at Leapfrog Enterprises Inc. (NYSE: LF), a developer of educational entertainment for children, from 2003 to 2007, where she led Asia Pacific business and served as the founding CEO of LeapFrog China. Ms. Thomas received her Master of Business Administration with a concentration in Marketing from the University of California, Berkeley, Haas School of Business. She has a Bachelor of Arts in International Finance from the Renmin University of China. Mr. Van Horne is a seasoned executive with an established a record of principal investing, M&A advisory across a wide range of industries, including technology, consumer products, and healthcare. Prior to joining Mark One in 2014, Mr. Van Horne was a lean and six sigma management consultant at Genpact (a General Electric company spinout) from 2012 to 2014. Mr. Van Horne has experience as a private equity and venture capital investor at Goldman Sachs where he was part of the Merchant Banking Division from 2005 to 2009. Further, Mr. Van Horne has experience as an M&A investment banker covering technology and business services industries at Wachovia Securities (a Wells Fargo company) from 2003 to 2005. Mr. Van Horne serves on the Board of Directors of Books for Kids Foundation, a non-profit organization focused on promoting early childhood literacy in underserved communities throughout New York City and greater metropolitan area; and Woman's Venture Fund, a leading non-profit organization focused on providing financing solutions for women-owned small business in the New York Tri-State area. Also, Mr. Van Horne was a member of the adjunct faculty at New York University, where he instructed M&A and venture capital subject matter. Mr. Van Horne holds a Bachelor of Science degree in Biology from Howard University, Washington, USA. Dr. Lenyoun is Head of Health for Mark One, where he ensures that Mark One's products achieve the mission of getting people healthier. Prior to Mark One, he worked with medical teams at Genentech, a leading biotechnology company from 2012 to 2014 where Dr. Lenyoun worked on over a dozen label expansions and product launches, as well as several initiatives that used technology to improve patient outcomes. Dr. Lenyoun holds a Bachelor of Arts in Visual and Environmental Studies from Harvard University, a Master of Science in Chemistry from the University of California, and a Medical Degree from Columbia University College of Physicians and Surgeons. He trained in Plastic and Reconstructive Surgery at Columbia University Medical Center and Weill Cornell Medical Center. Mr. Prevoteau is a startup veteran and seasoned technology leader currently responsible for software development at Mark One including backend systems, mobile applications, algorithm development and application of machine learning technologies. Mr. Prevoteau has experience building systems for LinkedIn, Autodesk, Citrix, Ford, St Jude's Children's Medical Center, and the U.S. Department of Health and Human Services while he served as Consulting Director at 6D Global Technologies from 2013 to 2015 and Mobile and Social Technology Lead at Razorfish Technology Platforms from 2011 to 2013. Mr. Prevoteau holds a Bachelor of Science in Management of Information Systems of Wright State University's Raj Soin College of Business. Ms. Dickinson is the owner and Chief Executive Officer of Venture Communications, a company she joined in 1988 and grew from a small, local firm to one of the largest independent marketing agencies in Canada. She is also the Chief Executive Officer of District Ventures and Youinc.com, companies that help market, fund and grow entrepreneurs and their companies. She is a two time best-selling author, frequent speaker and is best known to Canadians as one of the venture capitalists on the award-winning CBC series Dragons' Den. Ms. Dickinson has been recognized with honors, including Canada's Most Powerful Women Top 100, the Pinnacle Award for Entrepreneurial Excellence, as well as PROFIT and Chatelaine's Top 100 Women Business Owners and is a Marketing Hall of Legends inductee. Ms. Dickinson sits on the Leadership Council of the Perimeter Institute for Theoretical Physics, several boards including the Omers Venture advisory board and is a recipient of The Queen Elizabeth II Diamond Jubilee Medal. Ms. Dickinson is an Honorary Captain of the Royal Canadian Navy and the recipient of honorary degrees from Mount Saint Vincent University, Saint Mary's University and the Northern Alberta Institute of Technology. Anchor is a capital pool company within the meaning of the policies of the TSXV and the common shares of Anchor (the "Anchor Common Shares") are listed for trading on the TSXV. Anchor currently has 5,514,000 Anchor Common Shares outstanding, stock options outstanding to acquire 551,400 Anchor Common Shares at a price of CAD$0.10 per share until December 2, 2024, and agent's options outstanding to acquire 351,400 Anchor Common Shares at a price of CAD$0.10 per share until December 2, 2016. As at June 30, 2016, Anchor had cash and near cash assets, net of liabilities, of approximately CAD$190,000. Other Matters Concerning the Qualifying Transaction The completion of the Transaction is subject to the approval of the TSXV and all other necessary regulatory approvals. The completion of the Transaction is also subject to additional conditions precedent, including completion of the Mark One Private Placement and the Mark One Financing for gross proceeds of a minimum of CAD$10,000,000, shareholder approval of Anchor and Mark One, satisfactory completion of final due diligence reviews by the parties, board of directors approval of Anchor and Mark One, and certain other usual conditions for transactions of this nature. Concurrent with the closing of the Transaction, the current founding shareholders of Anchor will transfer within escrow an aggregate of 1,000,000 Anchor Common Shares at a price of CAD$0.07 per share to Mark A. Lawson, advisor to Mark One, subject to the receipt of all necessary regulatory approval including approval of TSXV. Anchor will apply to the TSXV for an exemption from the sponsorship requirements in connection with the Transaction on the basis of the Private Placement. There is no assurance that such exemption will be granted. If such exemption is not granted, Anchor will be required to engage a sponsor for the Transaction. Trading of the Anchor Common Shares is currently halted and will not resume until all documents required by the TSXV in respect of the Transaction have been filed and the TSXV is otherwise satisfied that the halt should be lifted. Anchor will issue a further news release when the TSXV has received the necessary documentation and trading of the Anchor Common Shares is to resume. Further information on the Transaction, including financial information on Mark One, will be provided in a subsequent news release. As indicated above, completion of the Transaction is subject to a number of conditions, including but not limited to, TSXV acceptance and shareholder approval. The Transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the Information Circular or Filing Statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of the Corporation should be considered highly speculative. Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) has in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. Neither Mark One nor Anchor will update these forward-looking statements to reflect events or circumstances after the date hereof other than as required by applicable securities laws or TSXV policies. Readers are therefore cautioned not to place undue reliance on any forward-looking statements. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Anchor. The securities of Anchor being offered have not been, nor will be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from U.S. registration requirements. This release does not constitute an offer for sale of securities in the United States.


Dean J.C.,Medical University of South Carolina | Clair-Auger J.M.,University of Alberta | Lagerquist O.,Northern Alberta Institute of Technology | Collins D.F.,University of Alberta
Frontiers in Human Neuroscience | Year: 2014

Motoneurons receive a barrage of inputs from descending and reflex pathways. Much of our understanding about how these inputs are transformed into motor output in humans has come from recordings of single motor units during voluntary contractions. This approach, however, is limited because the input is ill-defined. Herein, we quantify the discharge of soleus motor units in response to well-defined trains of afferent input delivered at physiologically-relevant frequencies. Constant frequency stimulation of the tibial nerve (10–100 Hz for 30 s), below threshold for eliciting M-waves or H-reflexes with a single pulse, recruited motor units in 7/9 subjects. All 25 motor units recruited during stimulation were also recruited during weak (<10% MVC) voluntary contractions. Higher frequencies recruited more units (n = 3/25 at 10 Hz; n = 25/25 at 100 Hz) at shorter latencies (19.4 ± 9.4 s at 10 Hz; 4.1 ± 4.0 s at 100 Hz) than lower frequencies. When a second unit was recruited, the discharge of the already active unit did not change, suggesting that recruitment was not due to increased synaptic drive. After recruitment, mean discharge rate during stimulation at 20 Hz (7.8 Hz) was lower than during 30 Hz (8.6 Hz) and 40 Hz (8.4 Hz) stimulation. Discharge was largely asynchronous from the stimulus pulses with “time-locked” discharge occurring at an H-reflex latency with only a 24% probability. Motor units continued to discharge after cessation of the stimulation in 89% of trials, although at a lower rate (5.8 Hz) than during the stimulation (7.9 Hz). This work supports the idea that the afferent volley evoked by repetitive stimulation recruits motor units through the integration of synaptic drive and intrinsic properties of motoneurons, resulting in “physiological” recruitment which adheres to Henneman’s size principle and results in relatively low discharge rates and asynchronous firing. © 2014 Dean, Clair-Auger, Lagerquist and Collins.


News Article | December 8, 2016
Site: www.prweb.com

Hanley Wood, the premier information, media, event, and strategic marketing services company serving the residential, commercial design, and construction industries, is pleased to announce the winners of the sixth annual CONCRETE SURFACES Polished Concrete Awards recognizing the industry’s most outstanding polished concrete projects. “This year’s entries show the industry’s continuing to expand beyond industrial and warehouse floor applications,” says CONCRETE SURFACES Editor Stephanie Johnston. “Contractors are becoming increasingly creative with products and processes for decorative, environmental, and other applications.” Education Northern Alberta Institute of Technology Centre for Applied Technology, Desco Coatings of Alberta Ltd, Edmonton, Alberta, Canada Descriptions and photos of all entries are available online at http://www.concretesurfacesmag.com. Winning projects will be published in the January 2017 issue of CONCRETE SURFACES, a supplement of CONCRETE CONSTRUCTION magazine published six times a year for contractors who specialize in polishing, coating, treating, stamping, staining, repairing, and rehabilitating concrete. CONCRETE SURFACES also is an official publication of World of Concrete. Hanley Wood is the premier company serving the information, media, and marketing needs of the residential, commercial design and construction industry. Utilizing the largest analytics and editorially driven Construction Industry Database, the company provides business intelligence and data-driven services. The company produces award-winning media, high-profile executive events, and strategic marketing solutions. To learn more, visit hanleywood.com.

Loading Northern Alberta Institute of Technology collaborators
Loading Northern Alberta Institute of Technology collaborators